// App-Quantinova.ai

P2-01-04 : Long Term Independent Prognostic Impact of Circulating Tumor Cells Detected before Neoadjuvant Chemotherapy in Non-Metastatic Breast Cancer: 70 Months Analysis of the REMAGUS02 Study

Researchers

Presenter

  • Bidard F-C

Principal Investigators

  • Delaloge S

  • Giacchetti S

  • de Cremoux P

  • Vincent-Salomon A

  • Marty M

  • Pierga J-Y

Medical Centers

  • Hospital Saint Antoine, Paris, France

  • Institut Curie, France

  • Institut Gustave Roussy, Nantes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved